News : 2015 : May

Study: Preventing Hepatitis B Reactivcation Due to Immunosuppresive Drug Treatments

Reactivation of the Hepatitis B Virus (HBV) can cause severe liver injury resulting in jaundice, liver failure, and death. This outcome continues to occur in patients receiving immunosuppressive drug therapy (ISDT) despite the ability to identify persons at risk with readily available and inexpensive blood tests for hepatitis B surface antigen and antibody to hepatitis B core antigen.

Read more about the study at JAMA

Read more »

Chairman Congratulates Faculty Members on New Award

Alejandro Diego Caicedo-Vierkant, PhD, Research Associate Professor, Division of Endocrinology, Diabetes and Metabolism, is the recipient of an award from The National Institute of Environmental Health Sciences (NIEHS),

Read more »

Chairman Congratulates Faculty on New Award

Matthias A. Salathe, MD, Division Chief, Vice Chair for Research, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, is the recipient of a Non-Competing Cystic Fibrosis Award.

Read more »

Chairman Congratulates Faculty on New Appointment

Olveen Carrasquillo, MD, MPH, Professor of Medicine and Public Health Sciences and Chief of the Division of General Internal Medicine is now a member of The Dissemination and Implementation Research in Health IDIRH).

Read more »

Announcement from the Chairman "Save the Date"

Roy E. Weiss, MD, PhD, Professor of Medicine, Chairman, Department of Medicine and Kathleen & Stanley Glaser Distinguished Chair in Medicine, cordially invites you to the Department of Medicine State of the Department Address and Awards

Read more »